4,0
21 déc. 2021
Employé (actuel), moins d'un an
Fremont, CA
Recommande
Approbation du PDG
Perspective commerciale
Avantages
Growing company, well compensated, generally good collaboration across regions
Inconvénients
Typical growing pains of a biotech evolving into midsize pharma, nothing particularly negative though